AzTrials
AzTrials

Lower Extremity ProblemNCT03625921

Transfemoral Powered Foot and Physical Therapy Study

A study testing Powered device with physical therapy and Powered device with standard of practice in people with Lower Extremity Problem and Prosthesis User, run by VA New York Harbor Healthcare System at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Individuals living with Transfemoral Amputation, enrolled equally at the Veterans Affairs New York Harbor Healthcare System (VANYHHS) and Walter Reed National Military Medical Center (WRNMMC), will be fit with a powered ankle-foot prosthesis. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Lower Extremity Problem, Prosthesis User
What is being tested?
Powered device with physical therapy and Powered device with standard of practice
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
17 Nov 2017to 14 Jan 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Unilateral TFA, any etiology
  • Experienced (> 6 months) microprocessor knee user
  • Less than or equal to 8 amputation related physical therapy sessions in the previous 6 months
  • At least 18 y.o.
  • High K2 or above ambulator
  • Able to walk a minimum of 30 m without an assistive device
  • Able to walk on treadmill for 5 minutes at self-selected speed with or without use of handrails

Who cannot join

  • Inability to tolerate wearing of a socket or a poorly fitting socket
  • Condition of intact limb prohibits prosthesis use (ulcers, sores, skin breakdown, burns, poor skin coverage, contractures, and severe heterotopic ossification)
  • The length of the residual limb prohibits socket/device fitting
  • Cognitive deficits or a mental health pathology limiting the ability to participate fully in the study or any deficit deemed by the PI to be detrimental to the completion of the study
  • Significant comorbidity, which would interfere with the study (for example: neuropathy, uncontrolled diabetes, receiving dialysis, have insensate feet or severe phantom pain or a history of skin ulcers)
  • Severe circulatory problems including peripheral vascular disease and pitting edema
Show all 12Show fewer
  • Pregnant women in the 2nd trimester or beyond or women who will be in the 2nd trimester within the enrollment period. This will be determined by asking the participant if she is pregnant or if they believe they may be pregnant. The question will only be asked at inclusion, as biomechanical changes will only be impacted if the woman is in the 2nd or 3rd trimester, and will not be impacted if the participant becomes pregnant while in the study.
  • Weigh more than 287 pounds at screening
  • Use of non-prescribed opioids or over-use of any prescription drugs
  • Major upper limb amputation
  • Currently uses a powered ankle-foot prosthesis as a primary prosthesis or used a powered ankle-foot device as a primary prosthesis in the previous 6 months
  • Any cardio-pulmonary, metabolic or integumentary diagnosis where walking for 15 minutes is contraindicated

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA New York Harbor Healthcare System

    New York, New York, 10010

Other trials in United States

About this study

Official title: Effects of a Powered Ankle-Foot Prosthesis and Device-Specific Physical Therapy on Function and Pain for Individuals Living With Transfemoral Limb Loss

Individuals living with Transfemoral Amputation, enrolled equally at the Veterans Affairs New York Harbor Healthcare System (VANYHHS) and Walter Reed National Military Medical Center (WRNMMC), will be fit with a powered ankle-foot prosthesis. All subjects will undergo a full gait analysis, functional measures, neurocognitive/cognitive, and pain assessment at baseline utilizing their current passive prosthesis. Subjects will then be randomly assigned into 2 equal groups: Powered device with an 8-session intensive, device-specific PT intervention (Group A); or powered device with current standard of practice (Group B), with includes basic device education, but no PT intervention. Subjects in Group A will undergo a 4-week PT-based intervention, which will isolate the contribution of device specific effects from rehabilitation effects. Group B will receive the current standard of practice, which does not include any formal rehabilitation. All users will undergo a full gait analysis, functional measures, neurocognitive/cognitive, and pain assessment after 4- and 8-weeks of use.

Being tested
Powered device with physical therapy, Powered device with standard of practice
Keywords
Physical Therapy, Powered Prosthesis, Biomechanical outcomes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Powered device with physical therapyBehavioural

    Subjects will be fit with a powered prosthesis (Ottobock emPOWER) and enrolled in a device-specific physical therapy (PT) program.

  • Powered device with standard of practiceBehavioural

    Subjects will be fit with a powered prosthesis (Ottobock emPOWER) and enrolled in the current standard of practice training, which includes basic device education and prosthetic training.

Study groups in NCT03625921
Study groupRoleWhat they receive
Powered device with physical therapyExperimentalSubjects will be fitted with a powered ankle-foot prosthesis (Ottobock emPOWER) and provided an intensive device-specific physical therapy (PT) intervention. The subjects will complete, on average, 8 PT training sessions lasting 30 - 45 minutes each. The subjects will also be provided with a home exercise program.
Receives: Behavioral: Powered device with physical therapy
Powered device with standard of practiceActive comparatorSubjects will be fitted with a powered ankle-foot prosthesis (Ottobock emPOWER) and provided the current standard of practice training for use of this powered prosthesis. The prosthetist will confirm a stable and comfortable alignment and educate the subject on proper home usage. Next, the subject will undergo a 45 - 60 minute training with a physical therapist that is characteristic of the current standard of practice.
Receives: Behavioral: Powered device with standard of practice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Gait Evaluation between PT and non-PT groups

    Biomechanical evaluation of gait with 3D motion capture while the individual is walking at several different speeds.

    Measured: Baseline, Week 4, and Week 8

  2. Change in 6 minute walk test between PT and non-PT groups

    The 6-minute walk test measures the distance an individual can walk in 6 minutes without help or encouragement.

    Measured: Baseline, Week 4, and Week 8

  3. Change in AmpPro between PT and non-PT groups

    The AmpPro is a 21-item instrument designed to measure basic prosthetic mobility of individuals with lower extremity amputation.

    Measured: Baseline, Week 4, and Week 8

  4. Change in the CHAMP between PT and non-PT groups

    The Comprehensive High-Level Activity Mobility Predictor (CHAMP) is a 4-item, more advanced instrument to measure prosthetic mobility for individuals in this study that scored > 38 on the AmpPro

    Measured: Baseline, Week 4, and Week 8

  5. Change from Baseline in Serial Subtraction at Week 4 and Week 8

    Serial Subtraction is a cognitive test where participants are given a random 3 digit number and are asked to subtract by 3s while they walk for 1 minute on a treadmill at a comfortable walking speed. Total number of errors will be documented. Serial subtraction will be performed at baseline using their current prosthetic foot and again at 4- and 8-weeks utilizing the powered prosthesis.

    Measured: Baseline, Week 4, and Week 8

  6. Change from Baseline in COWAT at Week 4 and Week 8

    The Controlled Oral Word Association Test (COWAT) is a cognitive test where participants are asked to list as many words as they can think of beginning with a certain letter while walking for 1 minute on a treadmill at a comfortable speed. The participants will complete 3 rounds (3 letters). The total number of unique words for each letter will be documented. COWAT will be performed at baseline using their current prosthetic foot and again at 4- and 8- weeks utilizing the powered prosthesis.

    Measured: Baseline, Week 4, and Week 8

  7. Change from Baseline in Category Test at Week 4 and Week 8

    The Category Test is a cognitive test where participants are asked to list as many words as they can think of belonging to a certain category while walking for 1 minute on a treadmill at a comfortable speed. The total number of unique words for the category will be documented. The category test will be performed at baseline using their current prosthetic foot and again at 4- and 8- weeks utilizing the powered prosthesis.

    Measured: Baseline, Week 4, and Week 8

  8. Change from Baseline in CNS Vital Signs at Week 8

    The CNS Vital Signs is a computerized neurocognitive assessment that assess 5 domains: memory, psychomotor speed, reaction time, complex attention, and cognitive flexibility. Participants will complete the online platform independently.

    Measured: Baseline and Week 8

Secondary outcomes (4)
  1. Change in Prosthetic Evaluation Questionnaire (PEQ) scores between PT and non-PT groups

    The PEQ is a self-report Visual Analog Scale questionnaire for persons with lower limb amputations who use a prosthesis. It consists of 9 validated subscales. They are used to evaluate the prosthesis and life with the prosthesis. Most questions in the PEQ use a visual analog scale format. Each visual analog scale is scored as a continuous numerical variable measured as the distance in millimeters from the left endpoint of the line to the point at which the respondent's mark crosses the line. Each line is 100 mm long and is always measured from the left (0-100). The questions are all worded so that a higher number (toward the right) will correspond with a more positive response. Subscale scores are calculated by computing the average (arithmetic mean) of all the questions which make up that particular scale. Only subscales are calculated. A total combined score is not calculated.

    Measured: Baseline, Week 4, and Week 8

  2. Change in Promis Pain Interference levels between PT and non-PT groups

    The Promis Pain Interference Scale is an 8-item self-report measure of pain interference over the last 7 days. There are 5 potential answers ranging from "not at all" to "very much" for participants to check off. Participants are only allowed to check off one answer per question.

    Measured: Baseline, Week 4, and Week 8

  3. Change in Quality of Life scores between PT and non-PT groups

    The Quality of Life Scale is a single item visual analog scale used to measure the participants' quality of life over the past four weeks or since their last visit. The visual analog scale is scored as a continuous numerical variable measured as the distance in millimeters from the left endpoint of the line to the point at which the respondent's mark crosses the line. The line is 100 mm long and is always measured from the left (0-100). On the left side of the scale (0 mm) it says "worst possible quality of life". On the right side of the scale (100 mm) it says "ideal quality of life, so the higher the score the more positive the response.

    Measured: Baseline, Week 4, and Week 8

  4. Change in Prosthetic Evaluation Questionnaire-Addendum (PEQ-A) 4 Week responses between PT and non-PT groups

    The PEQ-A 4 Weeks is a free response 2-item questionnaire in which the participant is asked about any falls and/or stumbles over the last four weeks or since his or her last visit.

    Measured: Baseline, Week 4, and Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Aug 2018
  2. Study start17 Nov 2017
  3. Primary completion14 Jan 2025
  4. Study completion14 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03625921
Sponsor's protocol ID
IRB #01643
Other IDs
CDMRP-OP160073
Status last verified
Apr 2025
First submitted
5 Jun 2018
Last updated
6 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Maikos JT, Pruziner AL, Hendershot BD, Herlihy DV, Chomack JM, Hyre MJ, Phillips SL, Sidiropoulos AN, Dearth CL, Nelson LM. Effects of a Powered Ankle-Foot Prosthesis and Physical Therapy on Function for Individuals With Transfemoral Limb Loss: Rationale, Design, and Protocol for a Multisite Clinical Trial. JMIR Res Protoc. 2024 Jan 26;13:e53412. doi: 10.2196/53412.

    PubMed 38277197

Questions about this trial

What is this clinical trial studying?

A study testing Powered device with physical therapy and Powered device with standard of practice in people with Lower Extremity Problem and Prosthesis User, run by VA New York Harbor Healthcare System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 6 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Gait Evaluation between PT and non-PT groups (time frame: Baseline, Week 4, and Week 8). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03625921, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in